Tenders Are Invited For Pharmaceutical Products-Open Framework Agreement On Pharmaceutical Discounts In Accordance With Section 130A (8) Sgb V With Any Time, So-Called Registration Model 2025-05

Pharmaceutical Products-Open Framework Agreement On Pharmaceutical Discounts In Accordance With Section 130A (8) Sgb V With Any Time, So-Called Registration Model 2025-05. The Present Announcement Serves To Conclude Agreements On The Active Ingredient Milnacipran, Daring Form: Hkp (Atc Code: N06ax17) With Pharmaceutical Companies Within The Meaning Of Section 130A (8) Sentence 1 Social Code, Fifth Book (Sgb V) (Discount Contracts). According To Section 130A (8) Sentence 1 Sgb V, The Request To Participate Is Only Directed To Pharmaceutical Entrepreneurs Or Employee Communities Of Pharmaceutical Entrepreneurs Within The Meaning Of Section 4 (18) Of The Medicines Act (Amg). It Is Not An Open Procedure, But A Publication Of The Request To Conclude/Join/Join Discount Contracts With Conditions For All Participants And Non -Negotiable Conditions Including The Amount Of The Discount. The Corresponding Information Under Point 2.1 As Well As On Point 5.1.12 Condition For The Assignment Of The Order_Hier: Tree Until Which The Offer Must Be Valid Are Only Due To The Systematics Of This Form. Contractual Partners Can Become An Unlimited Number Of Pharmaceutical Entrepreneurs Or Employee Communities Of Pharmaceutical Entrepreneurs Within The Meaning Of Section 4 (18) Of The Medicines Act (Amg). The Contract Is Concluded Or Accession By Signing The Required Completed Self-Declarations Or Evidence As Well As The Contract Or The Contracts Either: A) Handwritten (Written Form According To § 126 Bgb) By Post Or B) With A Qualified Electronic Signature (§ 126A Bgb) By Email To Openhouse.Abatt Contract [email protected]. The Early Start Of The Contract Is 01.07.2025, Provided The Contract And The Required Declarations Or Evidence Were Received By The Kbs At The Latest On June 5, 2025. The Start Of The Contract Is Therefore The 1St Of The Month, Which Follows The Month Of Receipt Of The Contract As Well As The Required Declarations Or Evidence At The Kbs, Provided That The Input Takes Place Up To The 5Th Of A Month; Otherwise The 1St Of The Month After Next. The Contracts End Automatically, Without A Termination Being Required As Soon As The Active Ingredient (E) Or The Active Ingredient Combination (S) Contractual Partners Are Established By Means Of A Formal Award Procedure. The Final Date For The Entrance Of Contributions Is 05.05.2027. In Any Case, The Contracts End On June 30, 2027.